- Home
- SFST vs SLP Comparison
SFST vs SLP Comparison
Compare SFST & SLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SFST | SLP |
|---|---|---|
| Founded | 1999 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | EDP Services |
| Sector | Finance | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 421.9M | 248.8M |
| IPO Year | 2012 | 1996 |
Fundamental Metrics
Financial Performance| Metric | SFST | SLP |
|---|---|---|
| Price | $52.20 | $12.17 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 6 |
| Target Price | ★ $64.00 | $25.00 |
| AVG Volume (30 Days) | 57.5K | ★ 352.3K |
| Earning Date | 04-23-2026 | 04-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 94.76 | N/A |
| EPS | ★ 3.72 | 0.03 |
| Revenue | $6,282,000.00 | ★ $59,577,000.00 |
| Revenue This Year | $10.47 | $2.64 |
| Revenue Next Year | $12.19 | $6.01 |
| P/E Ratio | ★ $14.05 | $407.00 |
| Revenue Growth | ★ 12.99 | 10.52 |
| 52 Week Low | $29.80 | $11.16 |
| 52 Week High | $62.00 | $36.43 |
Technical Indicators
Market Signals| Indicator | SFST | SLP |
|---|---|---|
| Relative Strength Index (RSI) | 36.45 | 34.88 |
| Support Level | $52.59 | $11.16 |
| Resistance Level | $56.73 | $13.84 |
| Average True Range (ATR) | 1.87 | 0.53 |
| MACD | -0.90 | 0.27 |
| Stochastic Oscillator | 19.33 | 61.76 |
Price Performance
Historical ComparisonAbout SFST Southern First Bancshares Inc.
Southern First Bancshares Inc is a bank holding company. The company engaged in the business of accepting demand deposits and savings deposits insured by the Federal Deposit Insurance Corporation (the FDIC), and providing commercial, consumer and mortgage loans to the general public of which a majority of the revenue is derived from the Commercial and Retail Banking segment which includes the provision of traditional deposit and lending products and services to its commercial and retail banking clients.
About SLP Simulations Plus Inc.
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.